Danny Chow
Radiation Oncology · Port Arthur, TXNPI 1083613038
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $624 of the $700 with a category attached, or 89.1%. It is spread thinly across 24 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $217 and has fallen 60.2% since, to $86 in 2025. That places this record below the midpoint for radiation oncology clinicians in TX, where the typical reported total is $554.
Across 35 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$105
- Rigel Pharmaceuticals, Inc.$81
- Astellas Pharma US Inc$42
- Genmab U.S., Inc.$39
- Caris MPI, Inc.$38
- Merck$34
- plus $361 from 18 others
What the payments were for
- Food & beverage$62489%
- Education$7611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $105 |
| Rigel Pharmaceuticals, Inc. | 4 | $81 |
| Astellas Pharma US Inc | 3 | $42 |
| Genmab U.S., Inc. | 2 | $39 |
| Caris MPI, Inc. | 1 | $38 |
| Merck | 2 | $34 |
| Amgen | 2 | $31 |
| AstraZeneca | 1 | $30 |
| Incyte Corporation | 2 | $28 |
| Beigene USA, Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Sanofi | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Dova Pharmaceuticals | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Novocure Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$700 in reported general payments places this provider in the 50th percentile of 418 radiation oncology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Port Arthur
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Robert TimmermanDallas$77K
- Abhilasha PatelHouston$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.